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Abstract 
Background: Dysnatremia is associated with adverse outcome in critically ill patients. Changes in patients or treat‑
ment strategies may have affected the incidence of dysnatremia over time. We investigated long‑term changes in the 
incidence of dysnatremia and analyzed its association with mortality.
Methods: Over a 21‑year period (1992–2012), all serum sodium measurements were analyzed retrospectively in 
two university hospital ICUs, up to day 28 of ICU admission for the presence of dysnatremia. The study period was 
divided into five periods. All serum sodium measurements were collected from the electronic databases of both ICUs. 
Serum sodium was measured at the clinical chemistry departments using standard methods. All sodium measure‑
ments were categorized in the following categories: <120, 120–124, 125–129, 130–134, 135–139, 140–145, 146–150, 
151–155, 156–160, >160 mmol/L. Mortality was determined at 90 days after ICU admission.
Results: In 80,571 ICU patients, 913,272 serum sodium measurements were analyzed. A striking shift in the pattern 
of ICU‑acquired dysnatremias was observed: The incidence of hyponatremia almost halved (47–25 %, p < 0.001), 
whereas the incidence of hypernatremia nearly doubled (13–24 %, p < 0.001). Most hypernatremias developed after 
ICU admission, and the incidence of severe hypernatremia (sodium > 155 mmol/L) increased dramatically over the 
years. On ICU day 10 this incidence was 0.7 % in the 1992–1996 period, compared to 6.3 % in the 2009–2012 period 
(p < 0.001). More severe dysnatremia was associated with significantly higher mortality throughout the 21‑year study 
period (p < 0.001).
Conclusions: In two large Dutch cohorts, we observed a marked shift in the incidence of dysnatremia from hypona‑
tremia to hypernatremia over two decades. As hypernatremia was mostly ICU acquired, this strongly suggests 
changes in treatment as underlying causes. This shift may be related to the increased use of sodium‑containing infu‑
sions, diuretics, and hydrocortisone. As ICU‑acquired hypernatremia is largely iatrogenic, it should be—to an impor‑
tant extent—preventable, and its incidence may be considered as an indicator of quality of care. Strategies to prevent 
hypernatremia deserve more emphasis; therefore, we recommend that further study should be focused on interven‑
tions to prevent the occurrence of dysnatremias during ICU stay.
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Background
Deranged plasma sodium concentrations expose all cells 
to hypotonic or hypertonic stress. Clinical manifesta-
tions of dysnatremia are primarily neurological and rapid 
changes in plasma sodium in either direction can cause 
severe, permanent, and sometimes even lethal brain 
injury [1]. The reported prevalence of dysnatremia in the 
intensive care unit (ICU) ranges between 6.9 and 17.7 % 
and varies according to the time of onset (i.e., on admis-
sion or later during ICU stay), the threshold for diagno-
sis, and the population being assessed [2].
Patients in the ICU are at risk of developing both 
hyponatremia and hypernatremia. Critical illness may 
result in increased or reduced activity of the antidiu-
retic hormone [3, 4]. Additional factors that predispose 
to hypernatremia include a reduced urinary concentrat-
ing ability, the inability to express thirst, no free access to 
water, and increased insensible losses [5, 6]. In addition 
to critical illness per se, factors contributing to hypona-
tremia include excess use of hypotonic fluids and drugs 
stimulating antidiuretic hormone secretion [7].
The severity of hyponatremia on ICU admission is a 
demonstrated predictor of mortality [8]. Even slightly 
abnormal sodium levels on ICU admission are indepen-
dently associated with poor outcome [2, 9]. Although 
ICU-acquired hyponatremia is less prevalent, it is also 
associated with an increased risk of hospital mortality 
[5]. ICU-acquired hypernatremia is also an independent 
risk factor for mortality and associated with increased 
ICU length of stay [10–13]. The relation between sodium 
derangement and mortality has been reported in medical, 
surgical, mixed, cardiac, cardiovascular surgery, trauma, 
and neurological ICUs [5, 10–15]. Finally, comparable to 
variability in serum glucose [16] or potassium [17], the 
magnitude of changes in sodium has also been associated 
with a higher risk of death in ICU patients [14, 15].
Based on our impression that hypernatremia has nowa-
days become more prevalent than hyponatremia in the 
ICU, we hypothesized that a shift in the incidence of 
hyponatremia and hypernatremia occurred during the 
past two decades. Therefore, the aim of this study was 
to analyze the long-term changes in the incidences of 
hyponatremia and hypernatremia in the ICU. Further-
more, we studied the association between dysnatremia 
and mortality.
Patients and methods
This retrospective study was performed in two cohorts 
of adult ICU patients obtained from the two largest ICUs 
in The Netherlands, including the University Medical 
Center Groningen (44 bed unit) and the Erasmus Medi-
cal Center (48 bed unit). From the ICU of the Univer-
sity Medical Center in Groningen, all patients admitted 
between 1992 and 2011 were analyzed, and from the 
ICU of the Erasmus Medical Center in Rotterdam, all 
patients admitted between 1998 and 2012 were analyzed. 
The 21-year study period was divided into five periods to 
detect shift in time: 1992–1996, 1997–2000, 2001–2004, 
2005–2008, and 2009–2012. Data on the type of admis-
sion (surgical, medical, etc.) were available for patients 
from Groningen but not from Rotterdam. Patients aged 
<15  years were excluded. Mortality was determined at 
90 days after ICU admission. The anonymized data anal-
ysis in this study was performed in accordance with the 
guidelines and Dutch legislation, and it was approved 
by the medical ethical committees of our institutions 
(Medisch Ethische Commissie, UMC Groningen, METc 
2014.264, MEC Erasmus MC MEC-2015-401). Since this 
concerned a retrospective study on routinely collected 
data, informed consent was not required by the ethical 
committees.
Serum sodium measurements
All serum sodium measurements during ICU admission 
until day 28 were collected from the electronic databases 
of both ICUs. Serum sodium was measured at the clini-
cal chemistry departments using standard methods (with 
a pre-analytic dilution, assuming a standard 7  % solid 
phase) or at the ICU with Radiometer 700 series blood 
gas analyzers with an ion-selective method that uses no 
pre-dilution. All sodium measurements (reference range 
135–145  mmol/L) were categorized as follows: <120, 
120–124, 125–129, 130–134, 135–139, 140–145, 146–
150, 151–155, 156–160, >160  mmol/L. The so-called 
soccer field plots was generated for the 1992–1996 and 
the 2009–2012 periods to display the relation between 
ICU day and the relative incidence of dysnatremia in all 
patients between ICU day 1 and day 28. This way of pres-
entation facilitates easier identification of trends in dys-
natremia during the ICU stay. In these plots, dysnatremia 
was categorized into similar groups as defined earlier.
Pharmacy data
The hospital pharmacy of the University Medical Center 
in Groningen provided a list of all infusions that were 
administered in the ICU over the period 1997 through 
2011. In addition to the total volume infused, the mean 
sodium content was also calculated.
Statistical analysis
Comparisons between means and medians were made 
with the Student’s t test and Mann–Whitney U test, 
respectively. Distributions were compared with the 
Chi-square test. Data are expressed as means with 
standard deviations. A p value <0.05 was considered 
statistically significant. Bonferroni correction was used 
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where appropriate. Statistical analysis was performed 
with SPSS (IBM, version 22).
Results
Patient characteristics
In the two centers 80,571 consecutively admitted ICU 
patients were included, in whom a total of 913,272 serum 
sodium measurements were performed (55 % from Gro-
ningen). Sixty-four percentage of patients were male; 
mean age was 60  ±  16  years, with a mean of 11  ±  20 
serum sodium measurements/patient. Table  1 shows 
the type of ICU admissions in Groningen over time. The 
case mix of patients remained relatively stable over the 
study period, except for a small increase in vascular and 
abdominal surgery, and a small decrease in cardiotho-
racic surgery. In the additional data file, the data selection 
(Additional file  1: Figure  1) and the frequency distribu-
tion of the number of admitted patients as a function of 
ICU day (Additional file 1: Figure 2) are provided.
Long‑term changes in dysnatremia
Figure  1 shows the change in distribution of serum 
sodium categories during ICU admission for the first 
time period (1992–1996, left panel) and the last time 
period (2009–2012, right panel). The figure clearly 
shows that hyponatremia was more common in the 
first period and that hypernatremia became more 
common in the last period. The figure also shows that 
in particular the incidence of hypernatremia increased 
during ICU admission (most notably in the first 
2  weeks) and remained stable until day 20. On ICU 
day 10, for example, the incidence of hypernatremia 
>155  mmol/L rose from 0.7  % in 1992–1996 to 6.3  % 
in 2009–2012 (p  <  0.001). Figure  2 shows a different 
graphical representation of the incidences of hypona-
tremia and hypernatremia during the five subsequent 
time periods. From this analysis, the decreasing preva-
lence of hyponatremia and the increasing incidence 
of hypernatremia are also clearly visible for the five 
consecutive time periods. For example, the incidence 
of hyponatremia <130  mmol/L decreased from 47 to 
25 % (p < 0.001) from the first time period (1992–1996) 
to the last time period (2009–2012), whereas the inci-
dence of hypernatremia > 150 mmol/L increased from 
13 to 24 % (p < 0.001) in the same time periods. Over 
time the use of ion-selective sodium measurements 
has increased with the implementation of ICU-based 
point-of-care systems from 56 to 79  % (p  <  0.001) in 
Groningen (Additional file  1: Table  1). However, the 
sodium levels determined by the ion-selective assay 
were 1.5  mmol/L (p  <  0.001) lower in the Groningen 
ICU patients. As the ion-selective sodium levels were 
lower while being used more frequently, this should 
not have contributed to the observed trend toward 
higher sodium levels. Although a clear difference in 
albumin levels and in particular glucose levels was 
observed between 1992 and 1996 and 2009 and 2011, 
their statistical relation with sodium levels was very 
limited (Figures  5, 6 and regression analysis in Addi-
tional file 1). 
When the changes in incidence of sodium abnormali-
ties were analyzed separately for the Groningen and Rot-
terdam ICUs (Additional file  1: Table  3, Figure  3), both 
ICUs showed a trend toward hypernatremia. When 
analysis was performed for patients with hypernatremia 
>150  mmol/L all subgroups except transplantation 
showed a trend towards a higher incidence of hyperna-
tremia in recent cohorts.
For the Groningen ICU, we also performed similar 
analyses for the top 35 routine laboratory measure-
ments that were most frequently performed. With 
the exception of chloride, albumin, hemoglobin, and 
glucose, no important shifts over time were observed 
(Additional file 1: Figures 4, 5, 6). From the 1997–2000 
to the 2009–2011 period, the mean sodium concen-
tration of the infused fluids in the Groningen ICU 
increased from 100 to 107  mmol/L (p  <  0.001; Addi-
tional file 1: Table 2).
Table 1 Type of ICU admissions in Groningen in the five time periods
1992–1996 1997–2000 2001–2004 2005–2008 2009–2011 Total
(n = 11,831) (%) (n = 8,875) (%) (n = 8,078) (%) (n = 8,378) (%) (n = 6857) (%) (n = 44,019) (%)
Admission via emergency department 19 12 15 16 18 16
Vascular, abdominal and other surgery 14 17 20 21 21 18
Neurosurgery 11 10 12 14 13 12
Transplant 2 2 2 2 1 2
Cardiothoracic surgery 51 48 42 41 42 45
Trauma 4 4 5 5 5 4
Medical and miscellaneous 20 19 18 18 17 18
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Mortality
Figure  3 shows the mortality rates with the vari-
ous serum sodium categories and time periods. Dys-
natremia was strongly associated with mortality and 
showed a U-shaped relationship. Figure  3 demonstrates 
that this relationship between dysnatremia and mortal-
ity remained largely unchanged over the 21-year study 
period. The overall mortality rose slightly from 13  % in 
1992–1996 to 15  % in 1997–2000, 16  % in 2001–2004, 
15 % in 2005–2008, and 16 % in 2009–2012 (p < 0.001).
Discussion
In this large retrospective dual-center study, we observed 
a consistent and marked shift in the incidence of dys-
natremia from hyponatremia to hypernatremia over 
a two-decade observation period. The incidence of 
hyponatremia nearly halved over the study period, 
whereas the incidence of hypernatremia almost doubled. 
The trend toward higher serum sodium levels was con-
sistently observed in both centers and seemed to be more 
important in Groningen center. To our knowledge, this 
clear shift from hyponatremia to hypernatremia has not 
been reported before. The increased number of studies 
that address hypernatremia instead of hyponatremia may 
reflect increased awareness of this problem in other cent-
ers as well [5, 9, 10, 13–15]. Our observation that most 
hypernatremia typically developed after ICU admission 
strongly suggests that changes in therapy are involved in 
this trend.
Although Fig.  1 shows that hypernatremia at ICU 
admission has also increased over time, it is in particular 
the increase of hypernatremia after ICU admission that 
is striking. Although we do not have the data to evaluate 
the etiology of the dysnatremia, we do want to speculate 
on several factors which might have played a role. Two 
treatment-related factors that may have contributed to 
the shift from hyponatremia to hypernatremia are the 
less liberal use of intravenous fluids in combination with 
wider use of diuretic treatment and the increased use of 
steroids and in particular hydrocortisone. In 2006 the 
ARDS clinical network performed a study comparing a 
conservative strategy (mostly accomplished by admin-
istration of furosemide) with a liberal strategy of fluid 
management in patients with acute lung injury [18]. 
This trial provided evidence that more restrictive fluid 
management in critically ill patients results in improved 
lung function and shortened duration of mechanical 
ventilation and intensive care stay [19]. Fluid restriction 
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Fig. 1 Time course of sodium derangements. Comparison of the development of hyponatremia and hypernatremia between the periods 
1992–1996 and 2009–2012. Sodium levels within the reference range are shown in green and progressively more marked derangements in yellow, 
orange, and red, respectively
Page 5 of 8Oude Lansink‑Hartgring et al. Ann. Intensive Care  (2016) 6:22 
may have contributed indirectly to the rising incidence 
of hypernatremia. Nevertheless, we have shown pre-
viously that more than one-third of the patients with 
ICU-acquired hypernatremia are actually still volume 
overloaded [11]. This phenomenon is explained by the 
combination of large volumes of (approximately) isotonic 
fluids and a reduced urinary concentrating ability. In 
line with these observations, it was recently shown that 
NaCl 0.9 % used to dilute drugs and keep catheters open 
contributes to the occurrence of ICU-acquired hyperna-
tremia [20]. In the group of patients with ICU-acquired 
hypernatremia, the plasma creatinine and dose of furo-
semide were also higher, again suggesting compromised 
urinary concentrating ability as an important contributor 
to hypernatremia.
The role of hydrocortisone in the treatment of septic 
shock has evolved over the last two decades. In 2002 a 
French multicenter RCT of patients in vasopressor-unre-
sponsive septic shock showed significant shock reversal 
and reduction of mortality rate in patients with relative 
adrenal insufficiency [21]. This led to a more promi-
nent role of hydrocortisone in guidelines for patients 
with septic shock. In 2008 the CORTICUS trial, a large 
European multicenter study failed to show a mortality 
benefit with steroid therapy [22]. Nevertheless, a recent 
study in a university ICU in The Netherlands showed that 
hydrocortisone was the seventh most frequently admin-
istered drug [20]. Even after several systematic analyses, 
the role of hydrocortisone in septic shock is still not set-
tled [23, 24], and a systematic review identified a greater 
risk of hypernatremia with the use of corticosteroids 
[23]. We have no data on renal function and the use of 
renal replacement therapy (RRT) over this period, but 
RRT did not change in this respect, namely continuous 
veno-venous hemofiltration with a substitution fluid with 
a sodium content of 140  mmol/L. The widespread use 
of dopamine in past decades may have helped to avoid 
hypernatremia, since dopamine is a natriuretic agent.
The clinical implication of our observations and those 
of others is that early identification of hypernatremia or 
preferably impending hypernatremia may help to reduce 
the incidence, severity, and duration of hypernatremia. 
It has been proposed to consider the development of 
hypernatremia during ICU stay as an indicator of quality 
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Fig. 2 Incidence of dysnatremia in five time periods. For five time periods spanning 1992–2012 the incidence of various degrees of hyponatremia 
and hypernatremia is shown. Note that for clarity the two normonatremic categories are not shown
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of care, because ICU patients depend fully on the com-
petence of the medical staff for prescribing fluids and 
these patients are frequently monitored with sampling 
of blood [25]. The impact from dysnatremia on morbid-
ity and mortality leads to extensive burden on healthcare 
resources [26]. It is sobering to note that this proposal to 
prevent hypernatremia [25] was made more than 15 years 
ago, and yet its incidence has only increased. Neverthe-
less, we still believe it may be possible to achieve the best 
of both worlds, i.e., combine the low hypernatremia levels 
observed in the 1990s and the low hyponatremia levels 
observed today. Since hypernatremia is a condition that 
takes several days to develop and also takes a relatively 
long time to correct (Fig.  1), prevention would be the 
most desirable strategy. Our own data (Additional file 1: 
Table  1) show that although the total infused volume 
decreased, unfortunately the sodium concentration of 
infused fluids has only increased over the years. A strat-
egy of timely administration of infusion fluids with lower 
sodium content in the face of imminent hypernatremia 
seems reasonable to pursue. In this regard, the trend to 
use balanced fluids with lower sodium concentrations 
than the 154  mmol/L in NaCl 0.9  % may help [27, 28]. 
Since patients more often arrive at the ICU with hyper-
natremia, this is also relevant for the emergency depart-
ment and operating room. When other risk factors for 
hypernatremia such as the administration of furosemide 
[20] or hydrocortisone are present, an even earlier switch 
to infusions with minimal sodium concentrations may 
be desirable. Monitoring of sodium concentrations is 
facilitated with modern point-of-care equipment. In the 
slipstream of glucose control, we have demonstrated that 
careful computer-guided potassium control is feasible 
with a clear reduction of abnormal potassium levels [17]. 
In fact, integration of potassium regulation with glucose 
control was very effective with marginal extra costs or 
time spent [29]. But implementing computerized sodium 
control will be considerably more challenging since more 
variables have to be taken into account. Although no 
study has shown that treatment of dysnatremia reduces 
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Fig. 3 Dysnatremia and mortality in five time periods. Mortality at 90 days shows a U‑shaped relation with sodium derangements. Note that the 
mortality associated with the various dysnatremia categories has not markedly changed over the years
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mortality, a large multicenter observational study 
recently showed that successful rapid correction of dys-
natremia was independently associated with survival 
[30]. The 28-day mortality in patients whose dysnatremia 
was corrected within 48 h was not significantly different 
from that in patients with normal serum sodium con-
centrations on ICU admission [30]. This finding suggests 
that the association between dysnatremia and mortality 
may be causal and could be improved by timely correc-
tion, although conclusive evidence should come from a 
randomized trial.
This study has a number of limitations. First, the identi-
fied trends in our two ICUs (large ICUs in university hos-
pitals in The Netherlands) may not apply to other types 
of ICUs. Second, in addition to treatment-related factors, 
patient-related factors may also have played a role. For 
example, admissions for traumatic brain injury may have 
changed over the years, but this was not clearly reflected 
in our analysis of type of ICU admissions (Table 1). Also 
hypernatremia in patients with severe traumatic brain 
injury typically develops within the first three days [31] 
and not at the considerably later time as shown in Fig. 1. 
We do not have the data on shifts in medication usage in 
our two centers to support out speculation on the etiol-
ogy of the dysnatremia. Data on sodium concentration 
in mmol/L of the administered infusions in the Gron-
ingen ICU show a significant increase over time (Addi-
tional file 1: Table 1). Data on hyperosmolar dye contrast 
administration, the use of citrate anticoagulation on RRT, 
or (par)enteral nutrition were also not analyzed. We were 
also not able to identify complications of dysnatremia. 
Likewise we could not reliably determine how often a dis-
astrous complication such as central pontine myelinolysis 
occurred [32]. Finally, historical comparisons are vulner-
able to all kinds of system changes that inevitably happen 
over time. This may be the case for sodium measurement. 
One study showed that the discrepancy between the 
direct assay and the indirect assay (which includes a dilu-
tion step) became larger as plasma albumin decreased 
[33], [34]. Because patients in the ICU are often hypoal-
buminemic, this may predispose to pseudohyperna-
tremia. However, the point-of-care measurements that 
use a direct sodium assay became more prevalent during 
the study period. Thus, pseudohypernatremia may have 
been more common in the past, making the incidence of 
true hypernatremia in earlier time periods even lower.
Conclusions
In two large cohorts of ICU patients, we found a shift 
in the incidence of dysnatremias. The incidence of 
hyponatremia decreased over the study period, whereas 
the incidence of hypernatremia increased. We suggest 
this shift is related to the increased use of diuretics and 
hydrocortisone. As ICU-acquired hypernatremia is often 
iatrogenic, it thus may be—to an important extent—
preventable, and its incidence may be considered as a 
quality indicator. The relation of dysnatremia with mor-
tality remained unchanged over the 21-year study period; 
therefore, we recommend that further study should be 
focused on interventions to prevent the occurrence of 
dysnatremias during ICU stay.
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